Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

IL1-TRAP, Rilonacept, in Systemic Sclerosis

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Regeneron Pharmaceuticals
Information provided by (Responsible Party):
Robert Simms, Boston University
ClinicalTrials.gov Identifier:
NCT01538719
First received: February 21, 2012
Last updated: March 29, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2017
  Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)